Literature DB >> 17251335

Telomeric IGH losses detectable by fluorescence in situ hybridization in chronic lymphocytic leukemia reflect somatic VH recombination events.

Iwona Wlodarska1, Christine Matthews, Ellen Veyt, Helena Pospisilova, Mark A Catherwood, Tim S Poulsen, Vera Vanhentenrijk, Rachel Ibbotson, Peter Vandenberghe, T C M Curly Morris, H Denis Alexander.   

Abstract

Routine interphase fluorescence in situ hybridization (FISH) analysis of chronic lymphocytic leukemia (CLL) with LSI IGH/CCND1 assay, applied to differentiate CLL from leukemic mantle cell lymphoma, identified a subset of cases (42/174) with translocation-like IGH signal pattern. To unravel the underlying 14q32/IGH aberrations, 14 of these cases were subjected to cytogenetic, detailed FISH, and V(H) mutation analyses. FISH identified cryptic losses of various portions of the IGHV region in all 14 cases. Fine mapping of these V(H) deletions revealed a strict correlation between their distal border and localization of the used VH gene, suggesting that they are not oncogenic but reflect physiological events accompanying somatic V-D-J assembly. This hypothesis was further supported by FISH analysis of 20 CLL and hairy cell leukemia cases with the known V(H) usage showing a constant loss of sequences proximal to the used gene, identification of V(H) deletions in normal B cells, and their exclusive demonstration in B cell malignancies, but not of T cell and myeloid linage. Given that these cryptic physiological VH losses in B cells may seriously complicate analysis of B cell leukemia/lymphoma and lead to false conclusions, FISH users should take them into consideration when interpreting IGH aberrations in these malignancies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17251335      PMCID: PMC1867431          DOI: 10.2353/jmoldx.2007.060088

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  22 in total

Review 1.  The mechanism and regulation of chromosomal V(D)J recombination.

Authors:  Craig H Bassing; Wojciech Swat; Frederick W Alt
Journal:  Cell       Date:  2002-04       Impact factor: 41.582

2.  Detection of illegitimate rearrangement within the immunoglobulin locus on 14q32.3 in B-cell malignancies using end-sequenced probes.

Authors:  T S Poulsen; A N Silahtaroglu; C G Gisselø; E Gaarsdal; T Rasmussen; N Tommerup; H E Johnsen
Journal:  Genes Chromosomes Cancer       Date:  2001-11       Impact factor: 5.006

Review 3.  Mechanisms of chromosomal translocations in B cell lymphomas.

Authors:  R Küppers; R Dalla-Favera
Journal:  Oncogene       Date:  2001-09-10       Impact factor: 9.867

Review 4.  The configuration of the immunoglobulin genes in B cell chronic lymphocytic leukemia.

Authors:  M J S Dyer; D G Oscier
Journal:  Leukemia       Date:  2002-06       Impact factor: 11.528

Review 5.  Molecular features of B-cell lymphoma.

Authors:  R Siebert; A Rosenwald; L M Staudt; S W Morris
Journal:  Curr Opin Oncol       Date:  2001-09       Impact factor: 3.645

6.  Translocation t(14;18) and gain of chromosome 18/BCL2: effects on BCL2 expression and apoptosis in B-cell non-Hodgkin's lymphomas.

Authors:  E Galteland; E A Sivertsen; D H Svendsrud; L Smedshammer; S H Kresse; L A Meza-Zepeda; O Myklebost; Z Suo; D Mu; P M Deangelis; T Stokke
Journal:  Leukemia       Date:  2005-12       Impact factor: 11.528

7.  Expression of Ig-beta (CD79b) by chronic lymphocytic leukemia B cells that lack immunoglobulin heavy-chain allelic exclusion.

Authors:  L Z Rassenti; T J Kipps
Journal:  Blood       Date:  2000-04-15       Impact factor: 22.113

8.  Multicolor-FICTION: expanding the possibilities of combined morphologic, immunophenotypic, and genetic single cell analyses.

Authors:  José Ignacio Martín-Subero; Ilse Chudoba; Lana Harder; Stefan Gesk; Werner Grote; Francisco Javier Novo; María José Calasanz; Reiner Siebert
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

Review 9.  Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.

Authors:  J J M van Dongen; A W Langerak; M Brüggemann; P A S Evans; M Hummel; F L Lavender; E Delabesse; F Davi; E Schuuring; R García-Sanz; J H J M van Krieken; J Droese; D González; C Bastard; H E White; M Spaargaren; M González; A Parreira; J L Smith; G J Morgan; M Kneba; E A Macintyre
Journal:  Leukemia       Date:  2003-12       Impact factor: 11.528

Review 10.  Interphase cytogenetics of hematological neoplasms under the perspective of the novel WHO classification.

Authors:  José Ignacio Martín-Subero; Stefan Gesk; Lana Harder; Werner Grote; Reiner Siebert
Journal:  Anticancer Res       Date:  2003 Mar-Apr       Impact factor: 2.480

View more
  7 in total

Review 1.  Malleable immunoglobulin genes and hematopathology - the good, the bad, and the ugly: a paper from the 2007 William Beaumont hospital symposium on molecular pathology.

Authors:  Adam Bagg
Journal:  J Mol Diagn       Date:  2008-08-07       Impact factor: 5.568

2.  Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia.

Authors:  Shelly R Gunn; Mansoor S Mohammed; Mercedes E Gorre; Philip D Cotter; Jaeweon Kim; David W Bahler; Sergey N Preobrazhensky; Russell A Higgins; Aswani R Bolla; Sahar H Ismail; Daphne de Jong; Eric Eldering; Marinus H J van Oers; Clemens H M Mellink; Michael J Keating; Ellen J Schlette; Lynne V Abruzzo; Ryan S Robetorye
Journal:  J Mol Diagn       Date:  2008-08-07       Impact factor: 5.568

3.  Deep sequencing and SNP array analyses of pediatric T-cell acute lymphoblastic leukemia reveal NOTCH1 mutations in minor subclones and a high incidence of uniparental isodisomies affecting CDKN2A.

Authors:  Kristina Karrman; Anders Castor; Mikael Behrendtz; Erik Forestier; Linda Olsson; Mats Ehinger; Andrea Biloglav; Thoas Fioretos; Kajsa Paulsson; Bertil Johansson
Journal:  J Hematol Oncol       Date:  2015-04-24       Impact factor: 17.388

4.  Identification of prognostic relevant chromosomal abnormalities in chronic lymphocytic leukemia using microarray-based genomic profiling.

Authors:  Marian Jpl Stevens-Kroef; Eva van den Berg; Daniel Olde Weghuis; Ad Geurts van Kessel; Rolph Pfundt; Matty Linssen-Wiersma; Marloes Benjamins; Trijnie Dijkhuizen; Patricia Jta Groenen; Annet Simons
Journal:  Mol Cytogenet       Date:  2014-01-09       Impact factor: 2.009

5.  Submicroscopic deletions of immunoglobulin heavy chain gene (IGH) in precursor B lymphoblastic leukemia with IGH rearrangements.

Authors:  Jungwon Huh; Yeung Chul Mun; Eun Sun Yoo; Chu Myong Seong; Wha Soon Chung
Journal:  Ann Lab Med       Date:  2014-12-08       Impact factor: 3.464

6.  Cytogenetic Abnormalities in Multiple Myeloma Patients at a Tertiary Healthcare Center in India

Authors:  Perumal Govindasamy; Prabu Pandurangan; Anil Tarigopula; Rama Mani; Chandra R Samuel
Journal:  Asian Pac J Cancer Prev       Date:  2019-01-25

7.  A high mutation rate of immunoglobulin heavy chain variable region gene associates with a poor survival and chemotherapy response of mantle cell lymphoma patients.

Authors:  Xianqian Li; Ning Wu; Bin Li
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.